“…In the past, chlorpromazine hydrochloride-associated cholestasis has been attributed to hepatic hypersensitivity reactions (Gutman, 1957; Zelman, 1959;Popper & Schaffner, 1959;Zimmerman, 1963), inhibition of bilirubin secretion (Hargreaves, 1965), alteration of bile viscosity (Sharma & Prasad, 1967), precipitation of biliaryproteins (Clarke & Denborough, 1971) and spasm of the sphincter of Oddi (Moyer et al, 1954;Menguy et al, 1955), all without convincing pathophysiological proof. Although there is some direct experimental evidence that inhibition of bile flow both in dogs (Stefko & Zbinden, 1963;Sharma & Prasad, 1967) and in perfused rat liver preparations (Clodi & Schnack, 1960;Kendler et al, 1971) occurs with chlorpromazine hydrochloride and is related to dose, no physicochemical studies have been carried out on the interactions of the drug with bile salts, the major organic anions in mammalian bile, and the substances responsible for much of bile-water flow (Wheeler, 1969;Erlinger, 1972). At physiological pH one would expect that bile salts (Plate 1), which are anionic detergent-like molecules (Carey & Small, 1972), and chlorpromazine hydrochloride (Plate 1), which is acationicdetergent (Scholtan, 1955; Attwood et al, 1974), would be incompatible in solution owing to coulombic interactions between their ionic groups.…”